Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).
about
Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agentWater exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applicationsDynamic Measurement of Tumor Vascular Permeability and Perfusion using a Hybrid System for Simultaneous Magnetic Resonance and Fluorescence Imaging.
P2860
Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Differentiation of angiogenic ...... ptical contrast agent (SIDAG).
@en
type
label
Differentiation of angiogenic ...... ptical contrast agent (SIDAG).
@en
prefLabel
Differentiation of angiogenic ...... ptical contrast agent (SIDAG).
@en
P2093
P2860
P356
P1476
Differentiation of angiogenic ...... ptical contrast agent (SIDAG).
@en
P2093
Alexander Wall
Angelika von Wallbrunn
Christoph Bremer
Lars Matuszewski
Michael Schirner
Peter Hauff
Silke Müller
Thorsten Persigehl
Walter Heindel
P2860
P2888
P356
10.1186/BCR1875
P577
2008-03-10T00:00:00Z
P5875
P6179
1020504825